2015
DOI: 10.1016/j.ygyno.2015.06.019
|View full text |Cite
|
Sign up to set email alerts
|

Why have ovarian cancer mortality rates declined? Part III. Prospects for the future

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
0
6

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 36 publications
(44 citation statements)
references
References 48 publications
0
38
0
6
Order By: Relevance
“…Few risk factors that increase the risk of ovarian cancer have been confirmed; these include hormone replacement therapy [38], talcum powder [39], high body mass index [40] and endometriosis [41] and are not considered here. The role of genetic predisposition in ovarian cancer is discussed in part III [9].…”
Section: Risk Factors For Ovarian Cancermentioning
confidence: 99%
See 2 more Smart Citations
“…Few risk factors that increase the risk of ovarian cancer have been confirmed; these include hormone replacement therapy [38], talcum powder [39], high body mass index [40] and endometriosis [41] and are not considered here. The role of genetic predisposition in ovarian cancer is discussed in part III [9].…”
Section: Risk Factors For Ovarian Cancermentioning
confidence: 99%
“…In part III, we discuss future prospects for reducing ovarian cancer mortality, which incorporate genetic testing, preventive surgery, screening and treatment [9]. …”
Section: Future Trendsmentioning
confidence: 99%
See 1 more Smart Citation
“…The decline in mortality is the consequence of a decline in ovarian cancer incidence, which was largely due to the introduction of oral contraceptives in 1960 and the expansion in their use until 1990 [1]. In Part III, we discuss potential approaches to standardize the treatment of ovarian cancer using an optimal combination of surgery and chemotherapy in order to improve the cure rate of ovarian cancer [59].…”
Section: Synopsismentioning
confidence: 99%
“…Это может быть одним из факторов расширения диагностики генетического тестирования для всех женщин в популяции, с последующей билатераль-ной овариэктомией для женщин, при любой опера-ции на брюшной полости [76].…”
unclassified